-
Annual Report 2022: Time to move to the next stage2024-10-21 -
HA130- Improve the quality of life for dialysis pa...2024-10-21 -
Jafron Recognized as National Enterprise Technolog...2024-10-21 -
HA380 hemoperfusion cartridge-- Essential treatmen...2024-10-21 -
Golden Bull Award! Jafron Wins Golden Bull Award ...2024-10-21 -
Expert Consensus on Artificial Liver Therapy2024-10-21 -
Mr. Jean Paul Menneguerre, Senior Head of the EMEA...2024-10-21 -
Jafron in Jordan: Facilitator of the Local Healthc...2024-10-21 -
ESICM: Getting to Know Jafron from Different Persp...2024-10-21
-
Annual Report 2022: Time to move to the next stage2024-10-21
-
HA130- Improve the quality of life for dialysis patients2024-10-21
-
Jafron Recognized as National Enterprise Technology Center2024-10-21
-
HA380 hemoperfusion cartridge-- Essential treatments for critical illness2024-10-21
-
Golden Bull Award! Jafron Wins Golden Bull Award for Highest Investment Value o...2024-10-21
-
Expert Consensus on Artificial Liver Therapy2024-10-21
-
Mr. Jean Paul Menneguerre, Senior Head of the EMEA markets of Jafron Biomedical ...2024-10-21
-
Jafron in Jordan: Facilitator of the Local Healthcare Industry2024-10-21
-
ESICM: Getting to Know Jafron from Different Perspectives2024-10-21
Jafron Biomedical Co., Ltd.
العنوان: رقم 98، طريق التكنولوجيا السادس، منطقة التكنولوجيا العالية، مدينة تشوهاي، الصين
البريد الإلكتروني: customerservice@jafron.com
الموقع الإلكتروني: https://ar.jafroninternational.com
Terms of Use｜Site Map｜ Cookie Notice｜ Privacy Notice
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
